Quantum BioPharma Stock Pops 20%, Retail Bullish Sentiment Builds After $1M Crypto Holdings Boost

Quantum BioPharma drew increased retail buzz on Monday following its announcement of a new $1 million Bitcoin and cryptocurrency investment, which increased its crypto holdings to $4.5 million.

The company’s shares climbed 19.61% to close at $12.26 on Monday before easing 2.85% to $11.91 in after-hours trading.

The board-sanctioned investment supports the company’s established strategy of employing digital assets to protect against currency fluctuations while generating potential shareholder value. 

Quantum BioPharma confirmed that all digital assets are secured by a certified custodian and that future funding activities could use cryptocurrency.

The company plans to modify its portfolio holdings according to current market trends.

Quantum owns 20.11% of Celly Nutrition Corp., which sells the over-the-counter Unbuzzd product and pays Quantum royalties up to $250 million before starting perpetual 3% royalties.

Meanwhile, its unit, Lucid Psycheceuticals, works on the preclinical multiple sclerosis therapy, Lucid-MS.

On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 4,200% increase in 24-hour message volume.

One user noted that the stock remains under the radar, suggesting it is still in its early stages despite growing interest. 

Another pointed out that the stock has posted gains while maintaining relatively low trading volume, describing the move as “steady.”

The stock has surged over 200% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.